[Federal Register Volume 65, Number 196 (Tuesday, October 10, 2000)]
[Notices]
[Page 60204]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-25885]



[[Page 60204]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, Medication Development Research.
    Date: November 2, 2000.
    Time: 10 am to 12 pm.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt--Arlington at Washington's Key Bridge, 1325 Wilson 
Boulevard, Arlington, VA 22209-9990.
    Contact Person: Mark Swieter, Health Scientist Administrator, 
Office of Extramural Affairs, National Institute on Drug Abuse, 
National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 
3158, MSC 9547, Bethesda, MD 20892-9547, (301) 435-1389.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, Medication Development Research.
    Date: November 2, 2000.
    Time: 12:30 pm to 1:30 pm.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt--Arlington at Washington's Key Bridge, 1325 Wilson 
Boulevard, Arlington, VA 22209-9990.
    Contact Person: Mark Swieter, Health Scientist Administrator, 
Office of Extramural Affairs, National Institute on Drug Abuse, 
National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 
3158, MSC 9547, Bethesda, MD 20892-9547, (301) 435-1389.

(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug 
Abuse Scientist Development Award for Clinicians, Scientist 
Development Awards, and Research Scientist Awards; 93.278, Drug 
Abuse National Research Service Awards for Research Training; 
93.279, Drug Abuse Research Program, National Institutes of Health, 
HHS)


    Dated: September 29, 2000.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 00-25885 Filed 10-06-00; 8:45 am]
BILLING CODE 4140-01-M